Davis's Drug Guide
edoxaban
General
High Alert Medication: This medication bears a heightened risk of causing significant patient harm when it is used in error.
Pronunciation:
e-dox-a-ban
To hear audio pronunciation of this topic, purchase a subscription or log in.Trade Name(s)
- Lixiana
- Savaysa
Ther. Class.
Pharm. Class.
factor xa inhibitors
There's more to see -- the rest of this topic is available only to subscribers.
Citation
Vallerand, April Hazard., and Cynthia A. Sanoski. "Edoxaban." Davis's Drug Guide, 20th ed., F.A. Davis Company, 2026. Anesthesia Central, anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110167/9/edoxaban.
Vallerand AHA, Sanoski CAC. Edoxaban. Davis's Drug Guide. F.A. Davis Company; 2026. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110167/9/edoxaban. Accessed June 26, 2026.
Vallerand, A. H., & Sanoski, C. A. (2026). Edoxaban. In Davis's Drug Guide (20th ed.). F.A. Davis Company. https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110167/9/edoxaban
Vallerand AHA, Sanoski CAC. Edoxaban [Internet]. In: Davis's Drug Guide. F.A. Davis Company; 2026. [cited 2026 June 26]. Available from: https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110167/9/edoxaban.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - edoxaban
ID - 110167
A1 - Sanoski,Cynthia A,
AU - Vallerand,April Hazard,
BT - Davis's Drug Guide
UR - https://anesth.unboundmedicine.com/anesthesia/view/Davis-Drug-Guide/110167/9/edoxaban
PB - F.A. Davis Company
ET - 20
DB - Anesthesia Central
DP - Unbound Medicine
ER -
